Israele - inglese - Ministry of Health

padagis israel pharmaceuticals ltd, israel - mebeverine hydrochloride - tablets - mebeverine hydrochloride 135 mg - mebeverine - mebeverine - irritable bowel syndrome and conditions included in this group such as: chronic irritable colon, gastro- intestinal spasm secondary to organic diseases

Namibia - inglese - Namibia Medicines Regulatory Council

aspen pharmacare - mebeverine hcl - tablets - mebeverine hcl tablets 135mg

Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mebeverine hydrochloride, quantity: 135 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; lactose monohydrate; magnesium stearate; microcrystalline cellulose; purified talc; povidone; titanium dioxide; macrogol 8000; hypromellose - cmebeverine tablets are indicated in the management of the irritable bowel syndrome ('irritable colon', 'spastic colon', 'functional bowel disorders', 'spastic constipation', 'nervous diarrhoea'). cmebeverine is used to treat the symptoms of this condition - i.e. abdominal pain and cramps, persistent, non-specific diarrhoea (with or without alternating constipation) and flatulence.

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

chemidex pharma limited - mebeverine pamoate - oral suspension - 50 mg/5ml

Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mebeverine hydrochloride, quantity: 135 mg - tablet, film coated - excipient ingredients: magnesium stearate; purified talc; microcrystalline cellulose; lactose monohydrate; sodium starch glycollate type a; povidone; titanium dioxide; macrogol 8000; hypromellose - mebeverine gppl tablets are indicated in the management of the irritable bowel syndrome ('irritable colon', 'spastic colon', 'functional bowel disorders', 'spastic constipation', 'nervous diarrhoea'). mebeverine gppl is used to treat the symptoms of this condition - i.e. abdominal pain and cramps, persistent, non-specific diarrhoea (with or without alternating constipation) and flatulence.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mebeverine hydrochloride, quantity: 135 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; povidone; sodium starch glycollate type a; purified talc; titanium dioxide; macrogol 8000; hypromellose - mebeverine gxp tablets are indicated in the management of the irritable bowel syndrome ('irritable colon', 'spastic colon', 'functional bowel disorders', 'spastic constipation', 'nervous diarrhoea'). mebeverine gxp is used to treat the symptoms of this condition - i.e. abdominal pain and cramps, persistent, non-specific diarrhoea (with or without alternating constipation) and flatulence.

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - mebeverine hydrochloride; ispaghula husks - granules for oral suspension - 3.5 g/135 milligram(s) - bulk-forming laxatives; ispaghula, combinations

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential generics ltd - mebeverine pamoate - oral suspension - 10mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - mebeverine pamoate - oral suspension - 10mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - mebeverine pamoate - oral suspension - 10mg/1ml